U.S. Court of Appeals for the Federal Circuit
Allergan Sales, LLC v. Sandoz, Inc.
This writing
- Type
- Opinion of the Court
- Filed
- Aug. 29, 2019
- Case
- Allergan Sales, LLC v. Sandoz, Inc.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Concurring opinion filed by Chief Judge Prost. Wallach, Circuit Judge. Appellees Allergan Sales, LLC and Allergan, Inc. (together, "Allergan") sued Appellants Sandoz, Inc. and Alcon Laboratories, Inc. (together, "Sandoz") in the U.S. District Court for the District of New Jersey ("District Court"), asserting that Sandoz's Abbreviated New Drug Application ("ANDA") No. 91-087 for a generic version of Allergan's ophtha…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.
Other writings in this case
| Type | Author | Filed |
|---|---|---|
| Opinion | Not attributed | Aug. 29, 2019 |
| Concurrence | Not attributed | Aug. 29, 2019 |